Novartis
The TA Access Strategy, HEOR, Pricing Head role at Novartis focuses on shaping market access strategies that translate scientific innovations into real value for payers, healthcare systems, and patients. This position involves developing integrated access and pricing strategies across the product lifecycle, building evidence, and supporting country teams in payer negotiations. The role requires strong leadership and cross-functional collaboration to influence development programs and co-create international pricing strategies.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Novartis didn’t post a salary, so this is our estimate from similar listings.
VP of Access Strategy & Payer Engagement
Ocular Therapeutix
Senior Director, Field HEOR
Revolution Medicines
Director, Field Health Economics & Outcomes Research (HEOR), Upper Midwest
City of Duncan, Oklahoma
ED, Payer & Pricing Strategy
Diversity Employment
Senior Director, HEOR & Evidence Strategy
Intellia Therapeutics
Global HEOR Strategy Lead
Denali Therapeutics